amycretin vs tirzepatide Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study Amycretin in obesity: Mechanisms, clinical

Total N = 6 750, sample size per each cohort/ancestry can be found in Table 1

doi: 10.37765/ajmc.2024.89510 [DOI] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.

omega-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress

Other precautions include monitoring for diabetic retinopathy if blood glucose falls rapidly, maintaining adequate hydration, and avoiding use in pregnancy or breastfeeding unless specifically advised by a specialist